NUTR:NASDAQNusatrip Incorporated Analysis

Technical signals show NUTR trading at $9, exactly on its 20‑day and 50‑day SMAs and modestly above the 200‑day SMA of 8.29, yet the RSI of 79 places the stock in overbought territory and the MACD histogram is negative, indicating a bearish momentum shift. Fundamentally, the company reports a 3.4% revenue growth but operates at a -0.37% profit margin, with negative EBITDA and operating cash flow exceeding $14 million, while its price‑to‑sales ratio of 74.6 and price‑to‑book of 13.9 suggest extreme overvaluation.
Risk considerations include a recent Nasdaq/SEC trading suspension (though operations remain normal), virtually zero trading volume implying high liquidity risk, a near‑zero beta and 0% 30‑day volatility that mask underlying market exposure, and concentration in the Indonesian travel market, adding medium geographic and regulatory risk.